Francesco Dentali

Author PubWeight™ 90.09‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review. Eur Heart J 2006 10.77
2 Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012 10.75
3 Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012 5.02
4 Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding. Arch Intern Med 2012 3.16
5 Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med 2007 2.97
6 Thrombosis prophylaxis in medical patients: a retrospective review of clinical practice patterns. Haematologica 2002 2.43
7 Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency. Ann Intern Med 2006 2.40
8 Home-treatment of deep vein thrombosis in patients with cancer. Haematologica 2005 2.00
9 Statins for acute ischemic stroke. Cochrane Database Syst Rev 2011 1.57
10 New direct thrombin inhibitors. Intern Emerg Med 2009 1.53
11 Plasma levels of matrix metalloproteinases and their inhibitors in hypertension: a systematic review and meta-analysis. J Hypertens 2012 1.52
12 Neutrophils and clinical outcomes in patients with acute coronary syndromes and/or cardiac revascularisation. A systematic review on more than 34,000 subjects. Thromb Haemost 2011 1.40
13 Is Procalcitonin Really Useful for Diagnosis and Prognosis of COPD Exacerbations Requiring Mechanical Ventilation? Respiration 2017 1.39
14 Seasonal and monthly variation in occurrence of hypertensive urgency. Intern Emerg Med 2012 1.39
15 Statins, fibrates, and venous thromboembolism: a meta-analysis. Eur Heart J 2009 1.08
16 Clinical approach to splanchnic vein thrombosis: risk factors and treatment. Thromb Res 2012 0.99
17 Retrievable vena cava filters: a clinical review. J Thromb Thrombolysis 2012 0.98
18 Tailoring warfarin induction doses to reflect individual and disease-specific factors. Am J Med 2005 0.95
19 5 flourouracil-induced apical ballooning syndrome: a case report. Blood Coagul Fibrinolysis 2009 0.94
20 Accuracy of emergency physician-performed ultrasonography in the diagnosis of deep-vein thrombosis: a systematic review and meta-analysis. Thromb Haemost 2012 0.93
21 The short- and long-term risk of venous thromboembolism in patients with acute spinal cord injury: a prospective cohort study. Thromb Haemost 2012 0.90
22 Evidence and clinical judgment: vena cava filters. Thromb Haemost 2014 0.88
23 Selecting patients for home treatment of deep vein thrombosis: the problem of cancer. Haematologica 2002 0.88
24 Body mass index is associated with the development of the post-thrombotic syndrome. Thromb Haemost 2003 0.87
25 Risk of bleeding in low-risk atrial fibrillation patients on warfarin waiting for elective cardioversion. Thromb Res 2011 0.86
26 Accuracy of nurse-performed compression ultrasonography in the diagnosis of proximal symptomatic deep vein thrombosis: a prospective cohort study. J Thromb Haemost 2014 0.85
27 The metabolic syndrome and the risk of thrombosis. Haematologica 2007 0.85
28 Traditional and non traditional risk factors in accelerated atherosclerosis in systemic lupus erythematosus: role of vascular endothelial growth factor (VEGATS Study). Autoimmun Rev 2008 0.85
29 Lipid profile changes in patients with rheumatic diseases receiving a treatment with TNF-α blockers: a meta-analysis of prospective studies. Ann Med 2014 0.85
30 Screening for thrombophilia and antithrombotic prophylaxis in pregnancy: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). Thromb Res 2009 0.83
31 Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens. Thromb Haemost 2016 0.83
32 Chronobiology of acute aortic rupture or dissection: a systematic review and a meta-analysis of the literature. Chronobiol Int 2014 0.82
33 Angiotensin II type 1 and type 2 receptor expression in circulating monocytes of diabetic and hypercholesterolemic patients over 3-month rosuvastatin treatment. Cardiovasc Diabetol 2012 0.82
34 Evidence and clinical judgment: Treatment of cerebral vein thrombosis. Thromb Haemost 2010 0.81
35 Splanchnic vein thrombosis: new risk factors and management. Thromb Res 2012 0.81
36 Presence of residual thromboemboli at least six months after a first episode of symptomatic pulmonary embolism: do perfusion scintigraphy and angio-computed tomography agree? Thromb Haemost 2009 0.80
37 Metabolic syndrome and hyperhomocysteinemia in patients with deep vein thrombosis: a case-control study. Haematologica 2007 0.80
38 Unsuspected pulmonary embolism in cancer patients: a narrative review with pooled data. Intern Emerg Med 2014 0.79
39 The effect of subclinical hypothyroidism on vitamin K antagonist treatment. Thromb Res 2011 0.79
40 Venous thromboembolism and arterial thromboembolism. Many similarities, far beyond thrombosis per se. Thromb Haemost 2008 0.79
41 Short-term prognosis of intracranial haemorrhage in patients on oral anticoagulant or antiplatelet drugs. Thromb Res 2013 0.79
42 Nonadherence with INR monitoring and anticoagulant complications. Thromb Res 2013 0.79
43 The initial phase of oral anticoagulation with warfarin in outpatients with deep venous thrombosis. Blood Coagul Fibrinolysis 2003 0.79
44 Venous thrombosis at unusual sites and the role of thrombophilia. Semin Thromb Hemost 2007 0.78
45 Mild antithrombin deficiency and risk of recurrent venous thromboembolism: a prospective cohort study. Circulation 2013 0.78
46 Homocysteine in vascular Behcet disease: a meta-analysis. Arterioscler Thromb Vasc Biol 2010 0.78
47 Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysis. Thromb Haemost 2013 0.78
48 Higher mortality rate in patients hospitalised for acute pulmonary embolism during weekends. Thromb Haemost 2011 0.78
49 Is there a role for timely diagnosis and early anticoagulant treatment of portal vein thrombosis in patients with liver cirrhosis? Intern Emerg Med 2008 0.78
50 Venous and arterial thrombosis in patients with HIV infection. Blood Coagul Fibrinolysis 2007 0.78
51 Residual venous obstruction in patients with a single episode of deep vein thrombosis and in patients with recurrent deep vein thrombosis. Thromb Haemost 2005 0.77
52 Antithrombin levels and the risk of a first episode of venous thromboembolism: a case-control study. Thromb Haemost 2012 0.77
53 Recurrence of ICH after resumption of anticoagulation with VK antagonists: CHIRONE study. Neurology 2014 0.76
54 In-hospital mortality for pulmonary embolism: relationship with chronic kidney disease and end-stage renal disease. The hospital admission and discharge database of the Emilia Romagna region of Italy. Intern Emerg Med 2012 0.76
55 Weight gain after acute deep venous thrombosis: a prospective observational study. Thromb Res 2003 0.76
56 The negative predictive value of D-dimer on the risk of recurrent venous thromboembolism in patients with multiple previous events: a prospective cohort study (the PROLONG PLUS study). Am J Hematol 2012 0.76
57 Accuracy of Nurse-Performed Lung Ultrasound in Patients With Acute Dyspnea: A Prospective Observational Study. Medicine (Baltimore) 2016 0.76
58 An unusual case of cerebral vein thrombosis in a patient with giant cell arteritis. Thromb Haemost 2008 0.76
59 How to manage patients on rivaroxaban in the emergency department: a statement of the Italian society of emergency medicine advisory board. Eur J Emerg Med 2016 0.76
60 Prognostic stratification of chronic heart failure in elderly population: are cardiopulmonary tests and BNP really valuable? Intern Emerg Med 2009 0.75
61 Neutrophil-to-lymphocyte ratio: a new prognostic factor even in patients with heart failure. Pol Arch Med Wewn 2016 0.75
62 Folic acid supplementation and cardiovascular diseases. JAMA 2007 0.75
63 Winter and venous thromboembolism: a dangerous liaison? Future Cardiol 2011 0.75
64 TB-402 for the prevention of venous thromboembolism in orthopaedic surgery: something new and promising, or not? Thromb Haemost 2013 0.75
65 Venous thromboembolism, age and hospitalisation: A potentially deadly combination. Thromb Haemost 2010 0.75
66 Statins and secondary prevention of ischemic and hemorrhagic stroke. Stroke 2008 0.75
67 Extended-duration venous thromboembolism prophylaxis for medical patients. Ann Intern Med 2010 0.75
68 Unmet clinical needs in the management of patients with splanchnic vein thrombosis. Intern Emerg Med 2010 0.75
69 Should the commonly accepted definition of "unprovoked venous thrombembolism" be revisited? Thromb Haemost 2012 0.75
70 Clinical Features, Short-Term Mortality, and Prognostic Risk Factors of Septic Patients Admitted to Internal Medicine Units: Results of an Italian Multicenter Prospective Study. Medicine (Baltimore) 2016 0.75
71 Prevention of in-hospital VTE: why can't we do better? Lancet 2008 0.75
72 Diagnosis and management of venous thromboembolism: Results of a survey on current clinical practice. Thromb Res 2009 0.75
73 Are statins effective in high-risk primary prevention? Arch Intern Med 2010 0.75
74 Combined assessment of thrombotic and haemorrhagic risk in acute medical patients. Thromb Haemost 2015 0.75
75 Treatment options for deep vein thrombosis. Expert Opin Pharmacother 2010 0.75
76 Effect of body weight on efficacy and safety of direct oral anticoagulants in the treatment of patients with acute venous thromboembolism: a meta-analysis of randomized controlled trials. Ann Med 2015 0.75
77 Dabigatran in nonvalvular atrial fibrillation: from clinical trials to real-life experience. J Cardiovasc Med (Hagerstown) 2017 0.75
78 Patient selection for thromboprophylaxis in medical inpatients. Expert Rev Cardiovasc Ther 2013 0.75
79 Upper extremity deep vein thrombosis and pulmonary embolism after coronary bypass surgery: a case report and preliminary results from a prospective study evaluating patients during cardiac rehabilitation. Ital Heart J 2004 0.75
80 Location of venous thrombosis in patients with FVL or prothrombin G20210A mutations: systematic review and meta-analysis. Thromb Haemost 2013 0.75
81 A survey of thrombosis prophylaxis use in patients with lower limb fractures. Thromb Haemost 2004 0.75
82 Abdominal pain as pulmonary embolism presentation, usefulness of bedside ultrasound: a report of two cases. Blood Coagul Fibrinolysis 2017 0.75
83 The embolic storm: dramatic peripheral complications of left ventricular thrombosis after myocardial infarction. Blood Coagul Fibrinolysis 2009 0.75
84 Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari Syndrome. Thromb Haemost 2017 0.75
85 [Cardiovascular disease and venous thromboembolism. Different disorders or possible intriguing association?]. Recenti Prog Med 2008 0.75
86 Intracranial hemorrhage recurrence on vitamin K antagonist: severity of the first episode and HASBLED score fail to identify high-risk patients from the CHIRONE study. Blood Coagul Fibrinolysis 2017 0.75
87 Atypical case of acute coronary syndrome due to coronary-pulmonary steal syndrome secondary to pulmonary embolism. Intern Emerg Med 2010 0.75
88 Novel risk factors for venous thromboembolism. Hematol Oncol Clin North Am 2010 0.75
89 The new oral anticoagulants, do they change the benefit vs. risk for thromboprophylaxis in association to ambulatory surgery? Curr Opin Anaesthesiol 2010 0.75
90 Venous ischemic syndromes. Front Neurol Neurosci 2012 0.75
91 A prognostic index for 1-year mortality can also predict in-hospital mortality of elderly medical patients. Intern Emerg Med 2015 0.75
92 How to predict short- and long-term mortality in patients with pulmonary embolism? Pol Arch Med Wewn 2015 0.75
93 The role of the metabolic syndrome in patients with provoked venous thromboembolic events. Thromb Haemost 2013 0.75
94 [Characteristics and clinical use of rivaroxaban for the treatment of atrial fibrillation and venous thromboembolism]. G Ital Cardiol (Rome) 2014 0.75
95 Incidence and diagnosis of pulmonary embolism in Northern Italy: a population-based study. Eur J Intern Med 2013 0.75